Syncom Healthcare Limited toset up a unit in Special Economic Zone in Pithampur (near Indore) with an investment of Rs 20.48 crore. Besides, it will also modernise its existing manufacturing unit in Dehradun with an investment of Rs 6.62 crore.

The company SEZ unit will have ultra-modern facility and will manufacture general dose drugs with a production capacity of one billion tablets and 1.5 billion capsules annually. The unit will also have another manufacturing block to produce Cephalosporin drug in both tablet and dry syrup form. This block will have production capacity of 4.5 million tablets per year and 7.5 million dry syrup phials per year.

The company, which markets and manufactures drugs and formulations, has gone public to raise funds through the issue of Rs 75 crore for 7.5 million shares through 100 per cent book building.